A Clinical Trial Looking at the Comparability of 2 Different Forms of Semaglutide

Inclusion criteria

• Male or female
• Aged 20-55 years (both inclusive) at the time of signing informed consent
• Body mass index (BMI) between 25.0 and 34.9 kilogram per meter square (kg/m^2) (both inclusive)

Exclusion criteria

• Female who is pregnant, breast-feeding or intends to become pregnant or is of childbearing potential and not using adequate contraceptive method
• Any disorder which in the investigator's opinion might jeopardise participant's safety or compliance with the protocol
• Use of prescription medicinal products or non-prescription drugs, except routine vitamins, topical medications, highly effective contraceptives and occasional use of paracetamol and acetylsalicylic acid, within 14 days prior to the day of screening
• Abuse or intake of alcohol, defined as any of the below:

• Known or suspected alcohol abuse within 1 year before screening (defined as regular intake of more than an average intake of 24 grams (g) alcohol daily for men and 12 g alcohol daily for women - 12 g of alcohol equals about 300 milliliters (mL) of beer or lager, 100 mL of wine, or 25 mL spirits).
• Positive alcohol test at screening.
• Abuse or intake of drugs, defined as any of the below:

• Known or suspected drug or chemical substance abuse within 1 year before screening
• Positive drug of abuse test at screening